VAS
TMO icon

Vestmark Advisory Solutions’s Thermo Fisher Scientific TMO Stock Holding History

Vestmark Advisory Solutions’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.85M Sell
15,662
-7,802
-33% -$3.75M 0.07% 284
2026
Q1 		$11.5M Buy
23,464
+4,920
+27% +$2.67M 0.13% 173
2025
Q4 		$10.7M Buy
18,544
+9,416
+103% +$5.32M 0.15% 141
2025
Q3 		$4.43M Buy
9,128
+1,028
+13% +$478K 0.08% 237
2025
Q2 		$3.28M Sell
8,100
-6,391
-44% -$2.67M 0.05% 291
2025
Q1 		$7.21M Buy
14,491
+7,235
+100% +$3.92M 0.19% 146
2024
Q4 		$3.77M Sell
7,256
-710
-9% -$390K 0.13% 163
2024
Q3 		$4.93M Buy
7,966
+1,367
+21% +$809K 0.18% 113
2024
Q2 		$3.65M Buy
6,599
+769
+13% +$441K 0.15% 148
2024
Q1 		$3.39M Sell
5,830
-913
-14% -$512K 0.15% 170
2023
Q4 		$1.97M Buy
6,743
+3,714
+123% +$1.8M 0.1% 232
2023
Q3 		$1.53M Sell
3,029
-8,176
-73% -$4.36M 0.11% 205
2023
Q2 		$5.85M Buy
11,205
+830
+8% +$448K 0.22% 113
2023
Q1 		$5.98M Sell
10,375
-254
-2% -$143K 0.26% 99
2022
Q4 		$5.85M Buy
10,629
+1,500
+16% +$795K 0.29% 79
2022
Q3 		$4.63M Buy
9,129
+141
+2% +$78.9K 0.26% 98
2022
Q2 		$4.88M Buy
8,988
+1,908
+27% +$1.05M 0.28% 82
2022
Q1 		$4.18M Buy
7,080
+326
+5% +$187K 0.24% 91
2021
Q4 		$4.51M Buy
6,754
+1,001
+17% +$625K 0.25% 86
2021
Q3 		$3.29M Buy
5,753
+406
+8% +$223K 0.22% 111
2021
Q2 		$2.7M Sell
5,347
-9
-0.2% -$4.25K 0.19% 130
2021
Q1 		$2.44M Sell
5,356
-348
-6% -$166K 0.22% 120
2020
Q4 		$2.66M Sell
5,704
-11
-0.2% -$5.16K 0.3% 87
2020
Q3 		$2.52M Buy
5,715
+169
+3% +$69.8K 0.34% 74
2020
Q2 		$2.01M Buy
5,546
+96
+2% +$32.2K 0.31% 83
2020
Q1 		$1.55M Buy
+5,450
New +$1.72M 0.3% 93
2019
Q4 		– Sell
-6,092
Closed -$1.77M – 500
2019
Q3 		$1.77M Buy
6,092
+416
+7% +$119K 0.29% 102
2019
Q2 		$1.67M Buy
5,676
+677
+14% +$186K 0.29% 103
2019
Q1 		$1.37M Buy
+4,999
New +$1.24M 0.24% 123

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Vestmark Advisory Solutions's TMO Position: Q2 2026 in Review

Vestmark Advisory Solutions reduced its Thermo Fisher Scientific (TMO) stake by 33% in Q2 2026, selling an estimated $3.75M and leaving 15,662 shares worth $7.85M. The position accounts for 0.07% of the portfolio, ranked #284.

Vestmark Advisory Solutions first reported a position in TMO in Q1 2019 and has held it in 29 quarters since. The position peaked at $11.5M in Q1 2026. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Vestmark Advisory Solutions held 15,662 shares of Thermo Fisher Scientific worth $7.85M as of Q2 2026.
  • Vestmark Advisory Solutions sold 7,802 Thermo Fisher Scientific shares in Q2 2026, an estimated $3.75M.
  • Thermo Fisher Scientific made up 0.07% of Vestmark Advisory Solutions's portfolio in Q2 2026, its #284 holding.
  • Vestmark Advisory Solutions first reported a position in Thermo Fisher Scientific in Q1 2019 and has held it in 29 quarters since.
  • Vestmark Advisory Solutions's Thermo Fisher Scientific position peaked at $11.5M in Q1 2026.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Vestmark Advisory Solutions's 13F filing for Q2 2026, filed 14 Aug 2026.